首页 | 本学科首页   官方微博 | 高级检索  
检索        

2003~2005年我院口服降糖药物利用分析
引用本文:辛海莉,蔡雯雯,郭蔚.2003~2005年我院口服降糖药物利用分析[J].药学实践杂志,2007,25(6).
作者姓名:辛海莉  蔡雯雯  郭蔚
摘    要:


Drug utilization analysis of oral hypoglycemic agents in our hospital during the period of 2003 ~ 2005
XIN Hai-li,CAI Wen-wen,GUO Wei.Drug utilization analysis of oral hypoglycemic agents in our hospital during the period of 2003 ~ 2005[J].The Journal of Pharmaceutical Practice,2007,25(6).
Authors:XIN Hai-li  CAI Wen-wen  GUO Wei
Abstract:To assess the drug utilization and tendency of progress of oral hypoglycemic agents in our hospital and to provide references for rational administration clinically. Methods: DDDs, sales quantities, sales expenses and the ratio of sales expenses sequencing to that of DDDs in our hospital during the period of 2003 ~ 2005 were analyzed statistically with the method of DDDs analysis. Results:The top two antidiabetic drugs according to DDDs were melbine ( dimethyl diguanide) and gliclazide three successive years. The DDDs of acarbose increased dramatically. Which blood glucose regulatsry drugs ranked lower, the ratio of sales expenses sequencing to that of DDDs of glipizide and gliclazide controlled release pellets was equal or about, whereas that of rosiglitazone, acarbose(glucobay) and glimepiride was less than 1. Conclusion:The study shows that the drug utilization of oral hypoglycemic agents in our hospital is basically rational and is in accordance with the trend of advancement and drug therapeutic strategies of diabetes mellitus.
Keywords:Oral hypoglycemic agents  defined daily dose (DDD)  DDDs  drug utilization  diabetes mellitus
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号